Taysha Gene Therapies Inc.
TSHA | NASDAQ
$5.16
+$0.12 (+2.38%)
Sep 22, 2026, 10:54 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | 5.49M | n/a | 1.99M | 2.3M | 2.02M | 1.79M | 1.11M | 3.41M | 3.6M | 4.75M | 2.4M | 4.71M | 2.5M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | 295K | 299K | 286K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 331K | 703K | 631K | 1.68M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | -295K | 5.19M | -286K | 1.99M | 2.3M | 2.02M | 1.79M | 1.11M | 3.41M | 3.6M | 4.42M | 1.69M | 4.08M | 823K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -47.35M | -43.49M | -28.3M | -34.02M | -26.75M | -21.42M | -19.93M | -25.9M | -21.3M | -24.33M | -16.25M | -15.63M | -23.38M | -16.56M | -18.7M | -25.46M | -33.37M | -49.65M | -49.72M | -50.68M | -40.77M | -32.09M |
Interest Income | 2.33M | 2.59M | 2.87M | 3.17M | 1.86M | 1.33M | 1.7M | 2.11M | 1.44M | 1.69M | 1.92M | 1.11M | 223K | 319K | 199K | 9K | 27K | 14K | 29K | 37K | 40K | 66K |
Pretax Income | -46.64M | -42.41M | -27.85M | -32.73M | -26.88M | -21.53M | -18.79M | -25.52M | -20.93M | -24.06M | 47.74M | -117.09M | -24.6M | -17.62M | -55.72M | -26.53M | -34.09M | -50.32M | -50.39M | -51.19M | -40.93M | -32.02M |
Net Income | -46.64M | -42.41M | -27.85M | -32.73M | -26.88M | -21.53M | -18.79M | -25.52M | -20.93M | -24.06M | 47.74M | -117.09M | -24.6M | -17.62M | -55.72M | -26.53M | -34.09M | -50.32M | -50.39M | -51.19M | -40.93M | -32.02M |
Selling & General & Admin | 12.15M | 9.68M | 8.83M | 8.28M | 8.6M | 8.16M | 6.63M | 7.9M | 7.34M | 7.08M | 6.72M | 8.26M | 5.29M | 8.12M | 5.66M | 8.68M | 9.87M | 11.47M | 11.81M | 11.15M | 10.13M | 8.24M |
Research & Development | 38.64M | 33.81M | 24.65M | 25.46M | 20.14M | 15.57M | 15.33M | 14.95M | 15.07M | 20.66M | 12.68M | 11.79M | 19.79M | 12.51M | 13.86M | 16.77M | 23.51M | 38.18M | 37.92M | 39.53M | 30.64M | 23.85M |
Other Expenses | -3.43M | -295K | n/a | n/a | n/a | n/a | n/a | 4.84M | n/a | n/a | 449K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 47.35M | 43.19M | 33.49M | 33.74M | 28.74M | 23.72M | 21.95M | 27.69M | 22.41M | 27.74M | 19.85M | 20.05M | 25.08M | 20.63M | 19.52M | 25.46M | 33.37M | 49.65M | 49.72M | 50.68M | 40.77M | 32.09M |
Interest Expense | 6K | 9K | 12K | 15K | 17K | 19K | 22K | 24K | 27K | 29K | 713K | 1.47M | 1.44M | 1.37M | 796K | 1.08M | 743K | 672K | 691K | 543K | 194K | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 47.35M | 43.49M | 33.79M | 34.02M | 28.74M | 23.72M | 21.95M | 27.69M | 22.41M | 27.74M | 19.85M | 20.38M | 25.78M | 21.27M | 21.2M | 25.46M | 33.37M | 49.65M | 49.72M | 50.68M | 40.77M | 32.09M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 369.04M | 366.63M | 319.71M | 353.31M | 297.99M | 269.31M | 204.94M | 267.82M | 232.82M | 231.25M | 186.96M | 125.7M | 64.24M | 63.26M | 56.39M | 40.94M | 40.14M | 38.17M | 38.11M | 38M | 37.48M | 36.99M |
Shares Outstanding (Diluted) | 369.04M | 366.63M | 319.71M | 353.31M | 297.99M | 269.31M | 204.94M | 267.82M | 232.82M | 231.25M | 186.96M | 125.7M | 64.24M | 63.26M | 56.39M | 40.94M | 40.14M | 38.17M | 38.11M | 38M | 37.48M | 36.99M |
EPS (Basic) | -0.13 | -0.12 | -0.08 | -0.09 | -0.09 | -0.08 | -0.09 | -0.10 | -0.09 | -0.10 | 0.26 | -0.93 | -0.38 | -0.28 | -0.99 | -0.65 | -0.85 | -1.32 | -1.32 | -1.35 | -1.09 | -0.87 |
EPS (Diluted) | -0.13 | -0.12 | -0.08 | -0.09 | -0.09 | -0.08 | -0.09 | -0.10 | -0.09 | -0.10 | 0.26 | -0.93 | -0.38 | -0.28 | -0.99 | -0.65 | -0.85 | -1.32 | -1.32 | -1.35 | -1.09 | -0.87 |
EBITDA | -46.23M | -42.11M | -28M | -32.43M | -26.59M | -21.23M | -18.46M | -25.21M | -20.58M | -23.71M | 48.82M | -115.29M | -22.46M | -15.62M | -53.25M | -25.17M | -33.08M | -49.39M | -49.49M | -50.48M | -40.65M | -31.99M |
EBIT | -46.63M | -42.4M | -28.3M | -32.72M | -26.87M | -21.51M | -18.76M | -25.5M | -20.9M | -24.03M | 48.45M | -115.62M | -23.16M | -16.25M | -54.93M | -25.45M | -33.35M | -49.65M | -49.7M | -50.64M | -40.73M | -32.02M |
Depreciation & Amortization | 400K | 295K | 299K | 286K | 277K | 283K | 304K | 294K | 322K | 325K | 366K | 331K | 703K | 631K | 1.68M | 277K | 273K | 260K | 209K | 166K | 85K | 32K |
Add to Watchlist
Select watchlists to add or remove TSHA